Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Halozyme Therapeutics (DE:RV7)
FRANKFURT:RV7
Halozyme (RV7) Technical Analysis
0 Followers
Summary of all the Indicators
Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Halozyme Therapeutics’s (RV7) Moving Averages Convergence Divergence (MACD) indicator is 0.76, suggesting Halozyme Therapeutics is a Sell.
Halozyme Therapeutics’s (RV7) 20-Day exponential moving average is 35.55, while Halozyme Therapeutics’s (RV7) share price is €37.16, making it a Buy.
Halozyme Therapeutics’s (RV7) 50-Day exponential moving average is 35.29, while Halozyme Therapeutics’s (RV7) share price is €37.16, making it a Buy.
Halozyme (RV7) Pivot Points
Classic
37.28
37.28
37.28
37.28
37.28
37.28
37.28
Fibonacci
37.28
37.28
37.28
37.28
37.28
37.28
37.28
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Halozyme (RV7) Moving Averages
MA5
36.63Buy
36.80Buy
MA10
36.51Buy
36.30Buy
MA20
35.00Buy
35.55Buy
MA50
34.91Buy
35.29Buy
MA100
36.52Buy
35.77Buy
MA200
35.24Buy
37.64Sell
Halozyme Therapeutics’s (RV7) 10-Day exponential moving average is 36.30, while Halozyme Therapeutics’s (RV7) share price is €37.16, making it a Buy.
Halozyme Therapeutics’s (RV7) 100-Day exponential moving average is 35.77, while Halozyme Therapeutics’s (RV7) share price is €37.16, making it a Buy.
Halozyme Therapeutics’s (RV7) stock price is €37.16 and Halozyme Therapeutics’s (RV7) 50-day simple moving average is 34.91, creating a Buy signal.
Halozyme Therapeutics’s (RV7) stock price is €37.16 and Halozyme Therapeutics’s (RV7) 100-day simple moving average is 36.52, creating a Buy signal.
Halozyme Therapeutics’s (RV7) stock price is €37.16 and Halozyme Therapeutics’s (RV7) 200-day simple moving average is 35.24, creating a Buy signal.
Halozyme (RV7) Technical Indicators
RSI (14)
61.08
Neutral
STOCH (9,6)
92.85
Sell
STOCHRSI (14)
96.30
Sell
MACD (12,26)
0.76
Sell
ADX (14)
19.71
Buy
Williams %R
3.81
Sell
CCI (14)
88.76
Neutral
ATR (14)
0.64
-
Ultimate Oscillator
61.62
Neutral
ROC
2.99
Buy
Halozyme Therapeutics’s (RV7) Relative Strength Index (RSI) is 61.08, creating a Neutral signal.
Halozyme Therapeutics’s (RV7) Trend Strength Indicator (ADX) is 19.71, creating a Buy signal.
Halozyme Therapeutics’s (RV7) Commodity Channel Index (CCI) is 88.76, creating a Neutral signal.
Halozyme Therapeutics’s (RV7) Price Rate of Change (ROC) is 2.99, creating a Buy signal.
FAQ
Is RV7 a Buy, Hold, or Sell?
Based on RV7’s technical indicators, RV7 is a Buy.
What is RV7’s RSI (14)?
RV7’s RSI (14) is 61.08, which suggests RV7 is a Neutral.
What is RV7’s MACD?
RV7’s MACD is 0.76, which suggests RV7 is a Sell.
What is RV7’s 5-day moving average?
RV7’s 5-day moving average is 36.63, which suggests RV7 is a Buy.
What is RV7’s 20-day moving average?
RV7 20-day moving average is 35.00, which suggests RV7 is a Buy.
What is RV7’s 50-day moving average?
RV7’s 50-day moving average is 34.91, which suggests RV7 is a Buy.
What is RV7’s 200-day moving average?
RV7’s 200-day moving average is 35.24, which suggests RV7 is a Buy.
What is RV7’s Williams % R (14)?
RV7’s Williams % R (14) is -3.81, which suggests RV7 is a Sell.
What is RV7’s CCI (14)?
RV7’s CCI (14) is 88.76, which suggests RV7 is a Neutral.
What is the share price of Halozyme Therapeutics?
Halozyme's share price is 37.16€.